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The eﬃcacy of decoction in extracting mycobactericidal compounds from Flourensia cernua (Hojase´) leaves and fractionation
with solvents having ascending polarity was compared with that of (i) ethanol extraction by still maceration, extraction with
a Soxhlet device, shake-assisted maceration, or ultrasound-assisted maceration, followed by fractionation with n-hexane, ethyl
acetate, and n-butanol; (ii) sequential extraction with n-hexane, ethyl acetate, and n-butanol, by still maceration, using a Soxhlet
device, shake-assisted maceration, or ultrasound-assisted maceration. The in vitro mycobactericidal activity of each preparation
was measured against drug-sensitive (SMtb) and drug-resistant (RMtb) Mycobacterium tuberculosis strains. The results of which
were expressed as absolute mycobactericidal activity (AMA). These data were normalized to the ΣAMA of the decoction fraction
set. Although decoction was inactive, the anti-RMtb normalized ΣAMA (NAMA) of its fractions was comparable with the
anti-RMtb NAMA of the still maceration extracts and significantly higher than the anti-SMtb and anti-RMtb NAMAs of every
other ethanol extract and serial extract and fraction. Hexane extracted, from decoction, material having 55.17% and 92.62% of
antituberculosis activity against SMtb and RMtb, respectively. Although the mycobactericidal activity of decoction is undetectable;
its eﬃcacy in extracting F. cernua active metabolites againstM. tuberculosis is substantially greater than almost all pharmacognostic
methods.
1. Introduction
In bioassay-directed fractionation of plant extracts to isolate
molecules that have activity against Mycobacterium tubercu-
losis or other bacteria, it is common to obtain inactive decoc-
tions and infusions [1–4]. Conversely, aqueous preparations
of plant extracts are the most active, harboring antioxidant
[5], anti-inflammatory [6], antidiabetic [7], cytotoxic [8],
and immunomodulatory [9] properties.
Due to this disparity, aqueous preparations are typically
skipped when new antituberculosis or antibiotic principles
are purified from a plant. Bioassay fractionation is generally
started with a polar organic solvent, such as ethanol or
methanol [10]. In contrast, through the ages, the eﬃcacy of
plant decoctions in treating many respiratory and infectious
ailments has been highly touted. Thus, omitting the aqueous
extraction step in antituberculosis bioassay fractionation
of a particular plant should be examined more carefully,
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because such an action might produce false-negative results,
wherein new, potentially valuable antituberculosis molecules
are discarded.
Decoction of Flourensia cernua (Hojase´) is a component
of Mexican traditional medicine. In northern Mexico, its
leaves are used as a decoction to treat indigestion, as an
expectorant and as a cure for respiratory infections, includ-
ing tuberculosis [11].
We investigated (i) whether decoction generates active
fractions against M. tuberculosis using solvents that have
disparate polarities; (ii) whether any of the four most rec-
ognized pharmacognostic methods (still maceration, extrac-
tion with a Soxhlet device, shake-assisted maceration, and
ultrasound-assisted maceration) and fractionation with n-
hexane, ethyl acetate, and n-butanol; or sequential extraction
with n-hexane, ethyl acetate, and n-butanol, using still
maceration, a Soxhlet device, shake-assisted maceration,
and ultrasound-assisted maceration is more eﬃcacious than
decoction in yielding preparations from F. cernua leaves
that are rich in antituberculosis activity; (iii) whether such
extracts are active against M. tuberculosis strains that are
sensitive or resistant to the five first-line antituberculosis
medications.
2. Methods
2.1. General Procedures. Organic solvents, reactive-grade n-
hexane (n-Hex), ethanol (EtOH), ethyl acetate (EtOAc), n-
butanol (n-BuOH), and methanol (MeOH) were pur-
chased from Productos Quı´micosMonterrey (Monterrey, NL
Me´xico). Dimethyl sulphoxide (DMSO) and the antibiotics
rifampin and ofloxacin were supplied by Sigma-Aldrich
Chemical Co., St. Louis, MO, USA.
2.2. Plant Material. Whole Flourensia cernua plants (2 kg)
were collected by Juan Antonio Luna de la Rosa at Galeana,
Nuevo Leo´n, Me´xico, in October, 2006 and authenticated by
the biologist Marı´a Consuelo Gonza´lez de la Rosa; a voucher
specimen (voucher no. 024027) has been deposited at the
herbarium of Facultad de Ciencias Biolo´gicas, Universidad
Auto´noma de Nuevo Leo´n. The plant material was dried
in an oven (J.M. Ortiz. Aparatos Ele´ctricos. S.A. de C.V.,
Monterrey, N.L. Me´xico) at 40◦C, and the leaves were
separated and ground using an electric mill (Molino Del Rey,
S.A. de C.V. San Nicola´s de los Garza, N.L. Me´xico).
2.3. Preparation of Extracts and Fractions. All extracts were
prepared from a batch of dry, ground F. cernua leaves (180 g)
and divided into 12 15 g portions. From each portion, one
or three crude extracts was obtained, as described below.
The extracts were designated by capital letters: (A) is the
decoction (DC) and (B to E) correspond to the ethanol
extracts that were prepared by still maceration (StMC (B)),
Soxhlet extraction (SXH (C)), ultrasound-assisted macer-
ation (UsMC (D)), and shake-assisted maceration (SkMC
(E)), respectively.
Three extracts were obtained with StMC from a unique
15 g portion of leaf powder that was subjected to successive
extractions with n-Hex (F), EtOAc (G), and EtOH (H). The
same procedure was also followed to obtain I–K using SXH,
L–N using UsMC, and O–Q using SkMCwith n-Hex, EtOAc,
and EtOH as successive extraction vehicles.
The fractions were obtained by liquid-liquid partition
(LLP), DC (A), and EtOH extraction (B to E). Each crude
extract was partitioned successively with n-Hex, EtOAc, and
n-BuOH. These fractions were named using the originating
extract plus a subindex in sequence—for example, n-Hex,
EtOAc, and n-BuOH fractions from DC (A) were termed A1,
A2, and A3, respectively.
2.4. Decoction. A batch of F. cernua leaves was prepared
by DC in the traditional mode of preparation [11]. Fifteen
grams of ground leaves was combined with 150mL double-
distilled water and boiled for 20min. The DC was filtered
twice—first through a cotton plug and then through filter
paper (Whatman no. 1)—and the resulting aqueous extract
(A) was freeze-dried and stored until use.
2.5. Generation of Crude Ethanol Extracts. Crude ethanol
extracts were obtained by StMC, SXH, UsMC, or SkMC.
StMC was performed by extracting the plant material
three times, each time with 300mL for 72 h of incubation
(3 × 300mL × 72h. SkMC) and SXH were performed on
a rotary shaker (PC Corning 6200, NY, USA) and a Soxhlet
apparatus, respectively, and the plant material was extracted
3 × 300mL × 24h at 100 rpm. UsMC was performed in an
ultrasonic bath (Cole Parmer 8853, Vernon Hill, IL, USA),
and the plant material was extracted 3×300mL×24h. Crude
ethanol extracts were filtered twice—first through a cotton
plug and then through filter paper (Whatman no. 1)—and
the solvent was evaporated under reduced pressure.
2.6. Generation of Extracts with Solvents of Ascending Polari-
ties. Individual 15 g portions dry leaf material were succes-
sively extracted with n-Hex, EtOAc, and EtOH by StMC,
SkMC, UsMC, or SXH. These extracts were termed F–Q, as
described above.
2.7. Fractionation of Decoction and Crude Ethanol Extracts by
Liquid-Liquid Partition. Each crude ethanol extract (1.0 g)
was suspended in 500mL H2O :MeOH (3 : 2, v/v). The
suspension was successively partitioned between n-Hex (3x,
2 : 1, 1 : 1, 1 : 1, v/v), EtOAc (3x, 2 : 1, 1 : 1, 1 : 1, v/v), and n-
BuOH (1x, 1 : 4, v/v). The hexane and butanol fractions were
simply separated, and the solvent was evaporated; the ethyl
acetate fraction was washed with saturated NaCl solution,
dried over anhydrous Na2SO4, filtered through filter paper,
and concentrated under reduced pressure.
2.7.1. Mycobacterium tuberculosis Strains. Two strains were
used in this study: Mycobacterium tuberculosis H37Rv (ATCC
27294 (SMtb)), sensitive to all five first-line antituberculosis
medications (streptomycin, isoniazid, rifampin, ethambutol,
and pyrazinamide), and M. tuberculosis CIBIN/UMF15:99
(RMtb), a clinical isolate that is resistant to these medica-
tions.
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2.7.2. Mycobactericidal Activity. The mycobactericidal activ-
ity of the extracts and fractions was measured as the minimal
mycobactericidal concentration (MBC)—the minimal con-
centration of each extract or fraction that killed the entire
culture in a 200 µL microplate well—by microplate Alamar
Blue assay (MABA), modified by Molina-Salinas et al.
[1]. Briefly, reference SMtb or RMtb cultures were added
to a suﬃcient volume of sterile Middlebrook 7H9 broth,
supplemented to achieve a turbidity that was equivalent
to that of McFarland’s no. 1 standard. This suspension
was further diluted (1 : 50) with the same culture medium
immediately before use. The organic extracts, decoction, and
their fractions were assayed in duplicate.
All tests were performed in sterile flat-bottomed 96-
well microplates (each well held 200 µL). Working F. cernua
preparations (100 µL) were assayed in a two-fold dilution
series in Middlebrook 7H9 broth, ranging from 200 µg/mL
to 6.25 µg/mL. Each microplate was incubated for 5 d at 37◦C
and 5% CO2 in a sealed plastic CO2-permeable bag (Ziploc;
Johnson and Son, Racine, WI, USA). After 5 days of incu-
bation, blue (metabolically inactive mycobacteria) or pink
(metabolically active mycobacteria) color was developed by
adding, to each microplate-well, 32 µL of a solution made
with 9 volumes Alamar Blue (Trek Diagnostic, Westlake, OH,
USA and 1 volume Tween 80 (Sigma).
The minimal inhibitory concentration (MIC) corre-
sponded to the highest dilution of each F. cernua preparation
that inhibited the mycobacteria growth (corresponding to
the blue well contiguous to the first pink well). The mycobac-
terial growth or its absence was certified by direct observa-
tion of each microplate well with an inverted microscope.
This was performed by comparing the appearance of cultures
in each experimental microplate well with the untreated
controls, which were placed in the same microplate. The
organic extracts, decoction, and their fractions that had
a MIC ≤ 100µg/mL were considered to be active. Then,
the active extracts were examined for their mycobactericidal
activity.
Immediately after the MIC was determined, 5 µL of the
last well that contained a blue suspension was transferred
to a new microplate that contained 195 µL of fresh culture
medium per well. During the transfer, special care was taken
to maintain the original relative position of each inoculum
in the new plate. The following cultures were also transferred
to a new microplate: (a) 5 µL of two untreated mycobacterial
suspensions (they were reinoculated separately, in triplicate);
(b) a two-fold dilution series of rifampin (2–0.06µg/mL)
and ofloxacin (16–0.5µg/mL). Three wells were inoculated
with 100 µL of fresh inoculum, as in the MABA, and three
additional wells were incubated with 200 µL of culture
medium only as negative controls. The microplates were
incubated and developed with Alamar Blue, as in the MABA.
2.7.3. Definitions. The minimal bactericidal concentration
(MBC) corresponded to the minimal concentration (in µg)
of each F. cernua preparation that did not allow a shift in
color in cultures that were reincubated in fresh medium—for
example, the MBC is the concentration of an F. cernua leaf
preparation, expressed in µg/mL, that kills 6× 105 mycobac-
teria in each well (6 × 106/mL). One mycobactericidal unit
(MBU) is equivalent to the one MBC but is expressed in µg
of solid material.
Absolute mycobactericidal activity (AMA) is defined as
the number of MBUs in the entire mass of solids in the whole
extract or fraction in 15 g dry F. cernua leaves, calculated per
the following sequence of equations.
2.7.4. Calculations
(A) To Determine the Solid Yields, in µg, of the Decoction or
Ethanol Extracts:
TESD,EE = YD,EE ×
(
15× 106)
100
, (1)
where TESD,EE is the total extracted solids in decoction or
ethanol extracts, expressed in µg; YE corresponds to the yield
of each extract, expressed as the percentage of the original
weight of ground, dry F. cernua leaves that were used to start
each procedure (15× 106 µg (Table 1)).
(B) To Determine the Solid Yields, in µg, of Each Fraction
Derived from the Decoction or Ethanol Extracts:
TESA1–E3 = TESD,EE × YA1–E3100 , (2)
where TESA1–E3 are the total extracted solids in each fraction
and YA1–E3 is the yield of fractions A1 to E3with respect to the
content of solids (µg) in the originating fraction (Table 2).
(C) To Estimate the Yield (in µg) of Solids in Successive Frac-
tions Obtained from a Unique Ground, Dry F. cernua Leaves:
TESF–Q = YF–Q ×
(
15× 106)
100
, (3)
where TESF–Q corresponds to the total extracted solids in
each fraction F to Q, and YF–Q is the yield of fractions F to
Q, respectively (Table 3);
TESF = TESD,EE × YF100 , (4)
where TESF is the total extracted solids in each fraction and
YF is the yield of each fraction with respect to the content of
solids in the originating fraction (Table 3);
TESF–Q = YF–Q ×
(
15× 106)
100
, (5)
where TESF–Q corresponds to the total extracted solids in
each fraction F to Q, YF–Q is the yield of fractions F to Q,
respectively (Table 3), and 15 × 106 is the original weight of
the ground, dry F. cernua leaves.
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Table 1: Yield and mycobactericidal activity of crude extracts of Flourensia cernua leaf obtained with diﬀerent extraction methods.
Extraction method Solvent Yielda
MBCb (µg/mL)
Resulting extract
SMtbc RMtbd
DC W 24.4 >100 >100 A
StMC EtOH 25.5 100 50 B
SXH EtOH 31.3 100 50 C
UsMC EtOH 22.7 100 50 D
SkMC EtOH 30.9 100 50 E
a
Recovering percentage with respect to 15 g dry ground leaves (%w/w); bmycobactericidal activity MBC was expressed as the minimal bactericidal activity
(MBC) that killed 100% of mycobacteria. cSMtb M. tuberculosis H37Rv strain sensitive to all five fist-line antituberculosis drugs; dRMtbCIBIN/UMF15:99,
resistant to the above drugs. DC: decoction, StMC: still maceration, SXH: Soxhlet extraction, UsMC: ultrasound-assisted maceration, and SkMC: shake-
assisted maceration; W: water; EtOH: ethanol. Rifampin showed an MBC = 0.062 and 100 µg/mL and ofloxacin MBC = 0.125 and 0.250µg/mL versus SMtb
and RMtb, respectively.
Table 2: Yields and mycobactericidal activity of fractions obtained by liquid-liquid partition of decoction and ethanol crude extracts of
Flourensia cernua.
Originating extracta
n-Hex EtOAc n-BuOH
Fraction (yieldb)
MBCc (µg/mL)
Fraction (yieldb)
MBCc (µg/mL)
Fraction (yieldb)
MBCc (µg/mL)
SMtbd RMtbe SMtbd RMtbe SMtbd RMtbe
A A1 (33.5%) 12.5 6.25 A2 (12.5%) 6.25 50 A3 (17.7%) 100 100
B B1 (24.7%) 25 25 B2 (42.7%) 100 25 B3 (5.5%) 100 100
C C1 (34.2%) 25 25 C2 (37.9%) 50 50 C3 (10.6%) 100 100
D D1 (25.3%) 25 25 D2 (25.8%) 50 25 D3 (11.3%) 100 50
E E1 (22.7%) 25 12.5 E2 (34.6%) >100 100 E3 (6.7%) 100 100
a
Decoction (A) or crude ethanol extracts (B–E) obtained with diﬀerent extraction methods (Table 1) were successively fractionated by liquid-liquid partition
with n-hexane (n-Hex), ethyl acetate (EtOAc), and n-butanol (n-BuOH) and assayed for their mycobactericidal activity. bYield was expressed as the percentage
of dry material recovered with respect to the corresponding originating extract A–E and then with respect to 15 g of ground dry leaves of F. cernua.
cMycobactericidal activity was expressed as the minimal bactericidal activity (MBC) that killed 100% of mycobacteria. dSMtb M. tuberculosis H37Rv strain
sensitive to all five fist-line antituberculosis drugs; eRMtb M. tuberculosis CIBIN/UMF15:99, resistant to the above drugs. In this experiment rifampin and
ofloxacin were included as internal standards, and these showed the same MBC reported in the experiments from Table 1.
15×106 is the original weight of the ground, dry F. cernua
leaves in all of these equations;
Total MBUs = AMA,
1MBU =MBC,
(6)
where MBC is the minimal bactericidal concentration, ex-
pressed in µg;
MBC = 1.0MBU,
AMA = TES
MBC
,
(7)
where TES is the total solids in each preparation, expressed
in µg.
3. Results
3.1. Decoction and Crude Ethanol Extracts from F. cernua
Leaves. Table 1 shows the results of the decoction and the
four ethanol extraction methods. SXH (C) and SkMC (E)
generated the highest yields of material; DC (A) and UsMC
(D) were less eﬃcacious, 1.3- and 1.4-fold lower than yields
of E, respectively.
Regarding anti-M. tuberculosis activity, decoction (A) was
inactive against the SMtb and RMtb strains, against both of
which the ethanol extracts (B–E) had poor mycobactericidal
activity. RMtb was twice as susceptible to all ethanol frac-
tions.
3.2. Yields and Mycobactericidal Activity of Fractions from
Decoction and Crude Ethanol Extracts. The yields and myco-
bactericidal activity of fractions by liquid-liquid partition of
the decoction (A) and ethanol (B–E) crude extracts (Table 1)
are listed in Table 2. The mycobactericidal activity resided
primarily in the low-polarity fractions (A1, B1, C1, D1, and
E1). The n-hexane fractions from the ethanol extract with
SXH (C1) and DC (A1) produced the highest mass of solids,
followed by UsMC (D1), StMC (B1), and SkMC (E1). The
diﬀerence in yield between (C1) or (A1) and (E1) was 7%
(1.5-fold). In contrast, the mycobactericidal activity of all n-
hexane fractions increased significantly compared with their
respective extracts.
The changes in mycobactericidal activity that were
observed during the partition of DC were the most dramatic
—the fraction that had the highest activity was obtained (A1)
from an inactive crude extract (A). The mycobactericidal
eﬀect of A1 against SMtb and RMtb was 2- and 4-fold higher,
respectively, than that of n-hexane fractions from the crude
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Table 3: Yields and mycobactericidal activity of F. cernua ground dry leaves extracts obtained by successive extraction with solvents of
increasing polarity using diﬀerent extraction methods.
Extraction method
n-Hex EtOAc EtOH
Extract (yielda)
MBCb (µg/mL)
Extract (yielda)
MBCb (µg/mL)
Extract (yielda)
MBCb (µg/mL)
SMtbc RMtbd SMtbc RMtbd SMtbc RMtbd
StMC F (9.0%) 50 12.5 G (4.8%) 50 12.5 H (16.6%) 100 50
SXH I (9.5%) 50 25 J (4.1%) 50 25 K (12.1%) 100 50
UsMC L (11.5%) 50 25 M (3.9%) 100 50 N (5.5%) 100 100
SkMC O (12.5%) 50 25 P (5.5%) 100 50 Q (17.1%) 100 50
n-Hex: n-hexane, EtOAc: ethyl acetate, EtOH: ethanol. StMC: still maceration, SXH: Soxhlet extraction, UsMC: ultrasound-assisted maceration, SkMC:
shake-assisted maceration. aExpressed as the percentage of 15 g dry ground of F. cernua leaves. bMycobactericidal activity was expressed as the minimal
bactericidal activity (MBC) that killed 100% of mycobacteria. cSMtb M. tuberculosis H37Rv strain sensitive to all five fist-line antituberculosis drugs;
dRMtbCIBIN/UMF15:99, resistant to the above drugs. In this experiment, rifampin and ofloxacin were included as internal standards. These showed the
same MBC than those determined in the experiments from Table 1.
ethanol extracts (B1, C1, D1, or E1). The mycobactericidal
activity of n-hexane fractions from the crude ethanol extracts
against SMtb increased 4- and 2-fold against SMtb and
RMtb, respectively.
In a subsequent extraction with EtOAc, the yields and
mycobactericidal activity of the resulting fractions varied
more widely than those obtained with n-Hex. The fractions
that had the lowest and highest content of solids came
from DC (A2) and StMC (B2), respectively (24.7% diﬀerence
between A2 and B2). In contrast, lower mycobactericidal
activity was observed in all ethyl acetate fractions (A2–
E2) with respect to those of n-hexane. The ethyl acetate
fractions from B and D crude extracts maintained their
mycobactericidal potency against RMtb while that of frac-
tions from A, C, and E fell 2- to 4-fold against SMtb.
Notably, ethyl acetate fractions from crude extract B had
4-fold lower mycobactericidal potency against SMtb versus
its corresponding n-hexane fraction, but its activity against
RMtb was maintained. Again, RMtb was more sensitive than
SMtb to several ethyl acetate fractions (B2, D2, and E2). The
n-hexane fraction E1 lost its mycobactericidal activity against
SMtb but maintained some activity against RMtb (Table 2).
The last serial extraction, performed with n-BuOH (A3–
E3), generated fractions that had the lowest content of solids,
ranging this from 6.7% (E3) to 17.7% (A3) of their respective
extract (Table 2).
In contrast to the ethyl acetate fractions, the mycobacte-
ricidal activity of n-butanol fractions was uniform and weak:
100 µg/mL against SMtb or 50 µg/ML to 100 µg/mL against
RMtb.
Material that was extracted with n-BuOH (B3 to E3,
Table 2) had the same mycobactericidal activity as crude
ethanol extracts against SMtb (Table 1, B to E); 50% RMtb
sensitivity was observed in fractions B3, C3, and E3 (Table 2);
D3 showed the same antimycobacterial activity as extract D
(Table 1).
3.3. Yields and Mycobactericidal Activity of Successive Extrac-
tions of F. cernua Leaf Powder with Solvents of Ascending
Polarity by Various Extraction Methods. Table 3 shows that
direct extraction of leaf powder with n-Hex was less eﬃcient
than with EtOH (Table 1); 16.5%, 21.8%, 11.2%, and 18.4%
less solid material was obtained with StMC (F), SXH
extraction (I), UsMC (L), and SkMC (O), respectively. The
most eﬃcacious method with n-Hex was SkMC (O), which
extracted 11.9% less material than decoction (A; Table 1).
Although less material was extracted by n-Hex versus EtOH
or hot water (DC), its mycobactericidal activity against SMtb
or RMtb was 2-fold higher than with EtOH; the extract that
was obtained with n-Hex and StMC was 4-times more active
against RMtb compared with the EtOH extract using the
same method (Table 1).
Direct extraction of leaf powder with n-Hex generated
15.7%, 24.7%, 10.2%, and 13.8% fewer solids than starting
the extraction from the crude ethanol extract (Table 2) with
StMC (F), SXH (I), UsMC (L), or SkMC (O), respectively.
The most productive method that used n-Hex directly was
SkMC (O), yielding 21% less material than decoction by n-
Hex fractionation (A1 (Table 2)).
The next extraction of residual material from the direct
extraction with n-Hex was performed with EtOAc (Table 3),
yielding 3.9% (M) to 4.8% (G). Themycobactericidal activity
of material obtained with EtOAc after direct extraction with
n-Hex (G, J, M, and P, using StMC, UsMC, and SXH, resp.,
(Table 3)) varied widely.
Tables 2 and 3 show the following findings: (1) mycobac-
tericidal activity (estimated as MBC) of G was 2-fold higher
than the mycobactericidal activity of B2 against both SMtb
and RMtb, using StMc; (2) the mycobactericidal activity of
J was equal to that of C2 against SMtb and two-fold higher
against RMtb, using SXH; (3) themycobactericidal activity of
M was two-fold lower than that of D2 against both SMtb and
RMtb, using UsMC, and (4) the mycobactericidal activity of
P was not comparable with that of E2 against SMtb and two-
fold higher than that of E2 against RMtb, using SkMC.
The third sequential extraction with EtOH (Table 3)
was slightly more productive than fractionation with n-
BuOH (Table 2), extracting with StMC extract H contained
11.11%more solids fraction B2. Using SXH, 1.5%more solid
material was extracted in K than in C3, and, with SkMC,
EtOH extracted 10.4% more solid material in E than n-
BuOH in E3. On the other hand, UsMC extracted 5.8% fewer
solids with EtOH in N (Table 3) than with n-BuOH in D3
(Table 2).
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Table 4: Absolute mycobactericidal activity against SMtb in F. cernua leaf preparationsa.
Extract (solvent) Fraction (solvent) Extraction or fractionation method AMAb (MBU) ΣAMAc NAMAd
A (W) DC ND NQ NQ
A1 (n-Hex) LLP 98,088
A2 (EtOAc) LLP 73,200
A3 (n-BuOH) LLP 6,478 177,766 1.0
B (EtOH) StMC 38,250 0.22
B1 (n-Hex) LLP 37,791
B2 (EtOAc) LLP 16,333
B3 (n-BuOH) LLP 2,104 56,228 0.32
C (EtOH) SXH 46,950 0.26
C1 (n-Hex) LLP 64,228
C2 (EtOAc) LLP 35,588
C3 (n-BuOH) LLP 4,977 104,793 0.59
D (EtOH) UsMC 34,050 0.19
D1 (n-Hex) LLP 34,459
D2 (EtOAc) LLP 17,570
D3 (n-BuOH) LLP 3,848 55,877 0.31
E (EtOH) SkMC 46,350 0.26
E1 (n-Hex) LLP 42,086
E2 (EtOAc) LLP ND
(E3) (n-BuOH) LLP 3,106 45,192 0.25
F (n-Hex) StMC 27,000
G (EtOAc) StMC 14,400
H (EtOH) StMC 24,900 66,300 0.37
I (n-Hex) SXH 28,500
J (EtOAc) SXH 12,300
K (EtOH) SXH 18,150 58,950 0.33
L (n-Hex) UsMC 34,500
M (EtOAc) UsMC 5,850
N (EtOH) UsMC 8,250 48,600 0.27
O (n-Hex) SkMC 37,500
P (EtOAc) SkMC 8,250
Q(EtOH) SkMC 25,650 71,400 0.40
a
Obtaining of extracts and their fractions as well as their correspondent yields and MBC is described in the footnotes of Tables 1–3. bAMA means absolute
mycobactericidal activity and is expressed as the number of mycobactericidal units (MBU) contained in the total mass of solids from an extract or fraction.
One MBU is equivalent to the minimal mycobactericidal concentration expressed in µg. The total content of solids in all extracts was calculated from yields of
each extract or fraction, considering that all of these were obtained from portions of 15 g leaf powder (Tables 1–3). The solid mass of fractions was calculated
considering the total solids of their correspondent extract. All calculations were performed using the equations and definitions described in Section 2. cΣAMA
is the sum of MUs in all fractions derived from decoction or ethanol extracts, or the sum of extracts that came from the same portion of leaf powder and
obtained with the same extraction method but with a diﬀerent solvent (n-Hex, EtOAc, and EtOH). dNAMA means normalized absolute mycobactericidal
activity. 1.00 = Sum of AMA in the decoction fractions A1–A3. ND means not detected and NQ not quantifiable.
Mycobactericidal activity against SMtb did not change
with respect to the material that was extracted with EtOAc,
but activity against RMtb doubled with StMC, SXH extrac-
tion, and SkMC. In contrast, mycobactericidal activity fell
50% with UsMC.
Table 4 shows that although DC was inactive against
SMtb and RMtb, the sum of the AMA values of its three
fractions (A1, A2, and A3) was higher than the AMA of any
crude ethanol extract (B–E) or the ΣAMA of its correspon-
dent fraction set.
In general, the NAMAs (normalized absolute mycobac-
tericidal activities) of fraction sets that were derived from
ethanol extracts (B1–B3 to E1–E3 (0.25–0.59)) were higher
than their corresponding extracts (B–E (0.32–0.44)). The
most active fraction set was prepared with a Soxhlet device
((C1–C3) NAMA = 0.59).
We observed similar results to those of Table 4 using
RMtb as the target (Table 5), with two major diﬀerences: (a)
the range in NAMA (0.36–0.50) of the fraction sets (A1–A3
to E1–E3) was considerably narrower than the corresponding
data in Table 4; the NAMAs of three of them were similar
(StMC (B1–B3), 0.50; SXH (C1–C3) and SkMC (E1–E3),
0.49); and (b) the NAMA (1.02) that corresponded to
the set of preparations that were obtained by sequential
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Table 5: Absolute mycobactericidal activity against RMtb in F. cernua leaf preparationsa.
Extract (solvent) Fraction (solvent) Extraction or fractionation method AMAb (MBU) ΣAMAc NAMAd
A (W) DC ND NQ NQ
A1 (n-Hex) LLP 196,176
A2 (EtOAc) LLP 9,150
A3 (n-BuOH) LLP 6,478 211,804 1.0
B (EtOH) StMC 76,500 0.36
B1 (n-Hex) LLP 37,791
B2 (EtOAc) LLP 65,331
B3 (n-BuOH) LLP 2,104 105,226 0.50
C (EtOH) SXH 93,900 0.44
C1 (n-Hex) LLP 64,228
C2 (EtOAc) LLP 35,588
C3 (n-BuOH) LLP 4,977 104,793 0.49
D (EtOH) UsMC 68,100 0.32
D1 (n-Hex) LLP 34,459
D2 (EtOAc) LLP 35,140
D3 (n-BuOH) LLP 7,695 77,294 0.36
E (EtOH) SkMC 92,700 0.44
E1 (n-Hex) LLP 84,172
E2 (EtOAc) LLP 16,037
E3 (n-BuOH) LLP 3,106 103,315 0.49
F (n-Hex) StMc 108,000
G (EtOAc) StMc 57,600
H (EtOH) StMc 49,800 215,400 1.02
I (n-Hex) SXH 57,000
J (EtOAc) SXH 24,600
K (EtOH) SXH 36,300 117,900 0.56
L (n-Hex) UsMC 69,000
M (EtOAc) UsMC 11,700
N (EtOH) UsMC 8,250 88,950 0.42
O (n-Hex) SkMC 75,000
P (EtOAc) SkMC 16,500
Q (EtOH) SkMC 51,300 142,800 0.67
a
Obtaining of extracts and their fractions as well as their correspondent yields and MBC is described in the footnotes of Tables 1–3. Definitions, acronyms,
symbols, and calculations are depicted Section 2 or in the foot note of Table 4.
extraction with StMC (F–H) was comparable with that of the
DC fraction set (A1–A3). Notably, the NAMA of the same
extracts (F–H) was 2.75-times more active against RMtb
(Table 5) than against SMtb (Table 4).
Excluding the NAMA of F–H against RMtb, the range in
NAMA of the preparations that were obtained by sequential
extraction (I–Q) was 0.42–0.67.
Regarding the extraction eﬃcacy of the solvents, n-Hex
yielded the best results, followed by EtOAC. The DC hexane
fraction (A1) contained 92.62% of the anti-RMtb activity of
theA1–A3 set (Table 5); the anti-SMtb activity in this fraction
was 37.45% lower (Table 4). In this case, EtOAC (fractionA2)
was slightly less eﬀective than n-Hex, generating preparations
that had 41.18% and 55.15% of the anti-SMtb activity,
respectively (Table 4).
Table 5 shows a similar pattern for the anti-RMtb activity
of fraction D2 (obtained with the aid of ultrasound (the AMA
of D1 was 44.58% and that of D2 to 45%of theΣAMAof D1–
D3). The anti-RMtb of fraction B2 (obtained with EtOAc and
StMC) was higher (57.84%) than that of B1 (obtained with
n-Hex). The range in anti-SMtb and anti-RMtb activities of
fractions from ethanol extracts that were obtained with n-
Hex (B1, C1–D1–E1) was 61.29% to 93.13% (Table 4) and
35.91% to 81.47% (Table 5), respectively.
Anti-SMtb and anti-RMtb activities in fractions B1,
C2, D2, and E2 (obtained with EtOAc) ranged from ND
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(not detected) (E2) to 61.29% and 15.52% to 62.10%,
respectively.
For the preparations that were obtained by successive
extractions with solvents of ascending polarity, n-Hex was
the most eﬃcient; anti-SMtb and anti-RMtb activities
ranged from 40.72% to 70.99% and 48.34% to 78.58%,
respectively (data calculated with respect to the ΣAMA of the
F–H, I–K, L–N, and O–Q sets; Tables 4 and 5).
The least eﬃcient solvent for extraction of anti-M. tuber-
culosis material from DC or ethanol crude extracts was
ethanol. In the DC preparation, anti-SMtb and anti-RMtb
activities were 3.65% and 3.05%, respectively. The anti-SMtb
and anti-RMtb activities of the ethanol fractions ranged from
3.74% to 6.89% and 2.0% to 9.96%, respectively.
With regard to successive extractions using solvents of
ascending polarity, in general, EtOH was more eﬃcacious
than EtOAc in extracting material that had anti-SMtb and
RMtb activities directly from ground, dry leaves. The AMA
ranges of the material that was extracted with EtOAc and
with EtOH against SMtb (expressed as a percentage of the
ΣAMA of each set (F–H, I–K, L–N and O–Q)), were 11.55%
to 21.72 and 16.98% to 37.56%, respectively. Against RMtb,
the ranges were 9.92% to 26.74% (EtOH) and 11.55 to
35.93% (EtOAc; data calculated with respect to ΣAMA of
each set of extracts).
4. Discussion
We have shown that decoction of F. cernua leaves is more
eﬀective than four of the most frequently used pharma-
cognostic methods in extracting metabolites that possess
mycobactericidal activity against SMtb and RMtb M. tuber-
culosis strains—except for sequential extraction by StMC
using solvents with ascending polarity whose eﬃcacy equaled
that of DC.
As far as we know, the ability of DC and subsequent
fractionation with solvents of ascending polarity to extract
anti-SMtb and anti-RMtb has never been used with any
medicinal plant.
DC fraction set had the highest NAMA against RMtb—
equivalent to the NAMA of the most active anti-SMtb set—
despite fact that DC did not have any activity against M.
tuberculosis, as has been reported for F. cernua and other
medicinal plants [1, 2, 4]. Furthermore, the sole n-Hex
fraction contained more than 92% and 55% of the anti-
RMtb and SMtb activities, respectively, of the DC fraction
set. The AMA of DC n-Hex was higher than that of the n-Hex
fractions from any of the ethanol extracts. These findings
suggest that (1) DC, followed by fractionation with n-Hex, is
more eﬃcacious than ethanol extraction alone or followed by
n-Hex fractionation, regardless of pharmacognostic method;
(2) SMtb is more resistant than RMtb to F. cernua metabo-
lites in the DC n-Hex fraction.
DC fractionation produced material having 41% more
anti-SMtb activity than the most eﬃcient method (extrac-
tion with ethanol, assisted with a Soxhlet device) and nearly
50% of the anti-RMtb activity in the fraction sets that were
derived from the more bioactive ethanol extracts, generated
by StMC, SXH, or SkMC. Moreover, the sole n-Hex DC
fraction harbored 46% more anti-RMtb activity than any
fraction set derived from ethanol extracts.
Regarding the sequential extraction with solvents of
ascending polarity, DC fractionation produced material
having 60% more anti-SMtb activity than the most pro-
ductive method (SkMC). In the case of the anti-RMtb,
DC fractionation yielded a pattern similar to that observed
against SMtb, with a unique exception: the NAMA of SkMC
fraction set against RMtb was practically equal to the NAMA
of DC fraction set.
It is intriguing that F. cernua metabolites are inactive
when dissolved in boiling water, and, after being submit-
ted DC to fractionation (primarily with n-hexane), these
molecules exhibit a very strong antituberculosis eﬀect in
MABA solutions, which are rich in ions.
We propose that anti-SMtb and anti-RMtb metabolites
in F. cernua leaves are amphipathic (possibly polar lipids),
because they were extracted well with hot water and n-Hex,
which represent both extremes of polarity. Water and n-
hexane have dielectric constants of 80 and 2, respectively
[12]. Generally, polar solvents have a high dielectric constant
and vice versa.
Assuming that the F. cernua antituberculosis molecules
are amphipathic, the compounds of interest might progress
from an inactive to an active form. This happens after
being submitted successively to boiling water, n-Hex, and an
aqueous solution, rich in ions (MABA’s). It is well known
that the molecular and supramolecular structures of amphi-
pathic compounds are strongly influenced by water and
aqueous solutions rich in ions [13]. Thus, when the putative
antituberculosis amphipathic molecules are passed into
a hydrophobic medium (n-Hex), these possibly change to
an intermediate conformation (not tested); when they are
returned to a hydrophilic environment, these are modified
again, producing active molecules or active suprastructures.
As Mexican people use a decoction of F. cernua leaves as
an antituberculosis remedy [11], the abundant but inactive
metabolites in this preparation must be activated, not by n-
Hex, but by a metabolic pathway, as occurs with isoniazid
[14], or during their absorption or transport.
Notably, RMtb was 2-times more susceptible than SMtb
to the n-hexane fraction of decoction. In contrast, RMtb
was 8-times more resistant than SMtb to the DC-EtOH
fraction. Nevertheless, this phenomenon did not occur with
fractions that were derived from the ethanol extracts or with
preparations from the successive extractions with solvents
having ascending polarity. These data suggest that hot water,
but not ethanol, can extract two classes of metabolites from
F. cernua leaves: agents who are more hydrophobic and active
against RMtb and compounds that are less hydrophobic
and more active against SMtb. These putative classes of
metabolites must be isolated and characterized.
In conclusion, decoction of F. cernua leaves combined
with n-Hex fractionation is more eﬃcient than currently
used pharmacognostic methods in extracting active metabo-
lites against M. tuberculosis. DC can extract a compound
that has valuable activity against RMtb with higher success
than any other procedure. Our findings support the use of
DC of F. cernua in Mexican traditional medicine to treat
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respiratory infections and engender the opportunity to treat
patients who have been infected by multidrug-resistant M.
tuberculosis strains.
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